Skip to content
akaturk Academic measurement
Sign in Sign up

OpenAlex topic

Parkinson's Disease and Spinal Disorders

This page lists works and academicians tagged with an OpenAlex topic. It is not a YÖKSİS primary or secondary field.

OpenAlex 1,072 works 15 author topics

Works

1,072 works

  1. Memantine for patients with Parkinson’xxs disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial 2010
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.7%

    No abstract yet.

  2. Memantine for patients with Parkinson’xxs disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial 2010
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.7%

    No abstract yet.

  3. Impact on health related quality of life of adult spinal deformity (ASD) compared with other chronic conditions 2014
    SJR Q1 JCR Q2 OpenAlex top 1% OpenAlex 99.6%

    No abstract yet.

  4. Motor assessment of upper extremity function and its relation with fatigue, cognitive function and quality of life in multiple sclerosis patients 2006
    OpenAlex 81.8%

    No abstract yet.

  5. Akinetic‐rigid and tremor‐dominant Parkinson's disease patients show different patterns of FP‐CIT Single photon emission computed tomography 2011
    OpenAlex top 10% OpenAlex 98.2%

    OBJECTIVE: To elucidate whether Parkinson's disease subtypes show a different pattern of Iodine-123 fluoropropyl-;carbomethoxy-3 β-(FP-CIT) single photon emission computed tomography (SPECT) binding in accordance with neuropathological findings. METHODS: We analyzed a database of consecutive patients with FP-CIT scan…

  6. Which Musculoskeletal Complications Are Most Frequently Seen in Type 2 Diabetes Mellitus 2008
    YÖKSİS SJR Q2 JCR Q4 OpenAlex 86.2%

    This study aimed to investigate the prevalence of the most frequently occurring hand and shoulder complications in type 2 diabetes mellitus patients. The presence of cheiroarthropathy, frozen shoulder, Dupuytren's contracture and trigger finger was assessed in 102 type 2 diabetes mellitus patients and 101 age- and sex…

  7. The effects of rasagiline on cognitive deficits in Parkinson s disease patients without dementia A randomized double blind placebo controlled multicenter study 2011
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 96.7%

    Cognitive impairment can occur at all stages of Parkinson's disease. Rasagiline is a selective monoamine oxidase type-B inhibitor that enhances central dopaminergic transmission. Dopamine is thought to be involved in certain cognitive processes such as working memory. We assessed the effects of rasagiline on cognitive…

  8. The effects of rasagiline on cognitive deficits in Parkinson s disease patients without dementia A randomized double blind placebo controlled multicenter study 2011
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 96.7%

    Cognitive impairment can occur at all stages of Parkinson's disease. Rasagiline is a selective monoamine oxidase type-B inhibitor that enhances central dopaminergic transmission. Dopamine is thought to be involved in certain cognitive processes such as working memory. We assessed the effects of rasagiline on cognitive…

  9. The effects of rasagiline on cognitive deficits in Parkinson s disease patients without dementia A randomized double blind placebo controlled multicenter study 2011
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 96.7%

    Cognitive impairment can occur at all stages of Parkinson's disease. Rasagiline is a selective monoamine oxidase type-B inhibitor that enhances central dopaminergic transmission. Dopamine is thought to be involved in certain cognitive processes such as working memory. We assessed the effects of rasagiline on cognitive…

  10. The effects of rasagiline on cognitive deficits in Parkinson s disease patients without dementia A randomized double blind placebo controlled multicenter study 2011
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 96.7%

    Cognitive impairment can occur at all stages of Parkinson's disease. Rasagiline is a selective monoamine oxidase type-B inhibitor that enhances central dopaminergic transmission. Dopamine is thought to be involved in certain cognitive processes such as working memory. We assessed the effects of rasagiline on cognitive…

  11. The Effects of Rasagiline on Cognitive Deficits in Parkinson's Disease Patients Without Dementia: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study 2011
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 96.6%

    Cognitive impairment can occur at all stages of Parkinson's disease. Rasagiline is a selective monoamine oxidase type-B inhibitor that enhances central dopaminergic transmission. Dopamine is thought to be involved in certain cognitive processes such as working memory. We assessed the effects of rasagiline on cognitive…

  12. The effects of rasagiline on cognitive deficits in Parkinson s disease patients without dementia A randomized double blind placebo controlled multicenter study 2011
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 96.6%

    Cognitive impairment can occur at all stages of Parkinson's disease. Rasagiline is a selective monoamine oxidase type-B inhibitor that enhances central dopaminergic transmission. Dopamine is thought to be involved in certain cognitive processes such as working memory. We assessed the effects of rasagiline on cognitive…

Academicians

15 academicians